Form CERT - Certification by an exchange approving securities for listing:
SEC Accession No. 0001354457-26-000393
Filing Date
2026-04-30
Accepted
2026-04-30 14:26:04
Documents
1
Effectiveness Date
2026-04-30

Document Format Files

Seq Description Document Type Size
1 COAG_8A_Cert_2114044.pdf CERT 409067
  Complete submission text file 0001354457-26-000393.txt   564698
Mailing Address 101 MAIN STREET SUITE 1220 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1220 CAMBRIDGE MA 02142 45 2138 7627
Hemab Therapeutics Holdings, Inc. (Filer) CIK: 0002114044 (see all company filings)

EIN.: 414241952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERT | Act: 34 | File No.: 001-43250 | Film No.: 26923452
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)